Inside the LEAF Trial: Testing GLP1 Therapy Before Ablation LEAF was a randomized, singlecenter clinical trial that enrolled 59 adults with atrial fibrillation and a body mass index of at least 27 kg/m who elected to undergo their first catheter ablation
ILU Collective offers physician-supervised medical weight loss programs using GLP-1 receptor agonist medications, including FDA-approved semaglutide (the active ingredient in Semaglutide (GLP-1) and Semaglutide (GLP-1 weight loss)) and tirzepatide (Tirzepatide (GLP-1/GIP) / Tirzepatide (GLP-1/GIP weight loss))
Can I take Clopidogrel and Gabapentin together
Increasing adoption of L-carnitine in functional drinks and energy beverages has strengthened market momentum
Nothing in this article is medical advice
We gathered GWAS summary-level data for 12 common types of psychiatric disorder, including schizophrenia, anxiety disorders, bipolar disorder, bulimia nervosa, PTSD, autism, OCD, anorexia nervosa, broad depression, MDD, and suicide or other intentional self-harm, from large-scale consortia